Clinical Trial Update: Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tacrolimus 0.1% versus clobetasol 0.05% for management of symptoms in oral lichen planus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Lichen Planus

Drugs mentioned

• Clobetasol 0.05% (Clobetasol)
• Tacrolimus 0.1% (Tacrolimus)

Snippet

Sponsor: University of Peradeniya | Conditions: Oral Lichen Planus | Phase 2 | Status: COMPLETED